Publications
- IC2PERMED: Fostering collaboration between Europe and China to enhance personalised medicine,W.Ricciardi, S.Boccia, M. di Marcantonio, F. Beccia, F.A.Causio, C. Cadeddu, T.Osti, S.Farina, C.Savoia, A. Maio, Open Access Government, 7 July 2023
- Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals’
education and citizens’ empowerment in personalised medicine, F. Beccia, F.A.Causio, I. Hoxhaj, H-Y. Huang, L.Wang, W.Wang, S.Farina, T.Osti, C.Savoia, C. Cadeddu, W. Ricciardi, S. Boccia, BMC Health Services Research, 14 June 2023 - A survey of experts on personalized medicine landscape in European Union and China, I. Hoxhaj, F. Beccia, A. Morsella, C. Cadeddu, W.Ricciardi, S. Boccia, BMC Health Services Research, 23 May 2023
- Research and innovation in personalized medicine: a descriptive synthesis of actors in the EU and China, F.A.Causio, I. Hoxhaj, F. Beccia, M. di Marcantonio, T. Strohäker, C. Cadeddu, W. Ricciardi, S. Boccia, Future Medecine, 17 May 2023
- An overview of Personalized Medicine landscape and policies in the European Union, F. Beccia, I. Hoxhaj, C. Castagna, T. Strohäker, C. Cadeddu, W. Ricciardi, S. Boccia, European Journal of Public Health, ckac103, /10.1093/eurpub/ckac103, 28 October 2022
- Big data and ICT solutions in the European Union and in China- A comparative analysis of policies in personalized medicine, F.A. Causio, I. Hoxhaj, F. Beccia, M. di Marcantonio, T. Strohäker, C. Cadeddu, W. Ricciardi, S. Boccia, Digital Health Volume 8: 1–11, 10 September 2022
- “Integrating China in the International Consortium for Personalized Medicine”: The Coordination and Support Action to Foster Collaboration in Personalized Medicine Development between Europe and China
Alisha Morsella, Chiara Cadeddu, Carolina Castagna, Ilda Hoxhaj, Michele Sassano, Chuihui Mary Wang, Lili Wang, Svetlana Klessova, Antonio Giulio de Belvis, Stefania Boccia, Walter Ricciardi
Public Health Genomics, 10.1159/000516264, 13/08/2021 - Personalized prevention and population health impact: how can public health professionals be more engaged?
Stefania Boccia, Walter Ricciardi
The European Journal of Public Health, Vol. 30, No. 3, 391–392
- COVID-19 infection: the China and Italy perspectives
Jun Chen, Hongzhou Lu, Gerry Melino, Stefania Boccia, Mauro Piacentini, Walter Ricciardi, Yin Wang, Yufang Shi and Tongyu Zhu.
8/06/2020, Cell Death and Disease - Transmission of SARS-CoV-2 and other infections at large sports gatherings: a surprising gap in our knowledge
Michele Sassano, Martin McKee, Walter Ricciardi and Stefania Boccia
29/05/2020, frontiers in Medicine
- How the Italian NHS is fighting against the COVID-19 emergency
Stefania Boccia, Fidelia Cascini, Martin McKee and Walter Ricciardi
8/05/2020, frontiers in Public Health - What other countries can learn from Italy during the COVID-19 pandemic
Stefania Boccia, Walter Ricciardi, John P.A. Ioannidis
7/04/2020, American Medical Association
Mapping Materials for Experts
- REPLAY : IC2PerMed Policies and programmes in Personalized Medicine – European Workshop – 23/11/20 – https://www.youtube.com/watch?v=A8nXrk7DOF8&t=3730s
Presentations
- IC2PerMed – An Overview of Project aims, activites and expected results – Pr. Stefania Boccia
- IC2PerMed: a bridge between ICPerMed and China – Part 1 – Chiuhui Mary Wang, PhD
- IC2PerMed: a bridge between ICPerMed and China – Part 2 – Lili Wang, MD
- Mapping of Personalised Medicine Policies and Programmes in Europe – Dr. Ilda Hoxhaj
- Mapping of Personalised Medicine Policies and Programmes in China – Sylvia Zhou
- Comparative analysis of PM efforts in Europe and China – Dr. Timo Strohäker
- Shifting the mapping results in a roadmap for PM: next steps for the knowledge synthesis on the identification, transferability and scaling up of international standards in PM – Dr. Chiara Cadeddu
Public deliverables
- IC2PerMed Deliverable 1.1 – Scoping paper: Review on health research and innovation priorities in Europe and China
- IC2PerMed Deliverable 1.2 – Map of major funding agencies and stakeholders in Europe and China
- IC2PerMed Deliverable 1.3 – Towards closer EU-China collaboration in Personalised Medicine
- IC2PerMed Deliverable 1.4 – IC2PerMed Roadmap
- IC2PerMed Deliverable 4.4 – High Level Symposium: Health Policy & Personalised Medicine for Cancer – projecting the EU-China collaboration on the global arena